Welcome to PsychU!

Neurocircuitry Of Depression

During this webinar our speakers will begin with a brief overview of the history of neurocircuitry therapeutics. They will then introduce the core brain networks, and the current state of the… Read More

The Neurobiology Of Endocannabinoids

Hear from Chloe Liu, Ph.D., a Medical Science Liaison with Otsuka Pharmaceutical Development & Commercialization, Inc., as she examines the historical research discoveries and underlying neurobiological mechanisms of the endocannabinoid… Read More

Revisiting Cognitive Deficits In Bipolar Disorder

Neurocognitive deficits are commonly experienced by individuals living with bipolar disorder. Bipolar disorder is known to affect attention, processing speed, verbal learning and memory, and executive functions, including working memory… Read More

The Neurobiology Of Opioids

Hear from Chip Meyer, Ph.D., a Medical Science Liaison with Otsuka Pharmaceutical Development & Commercialization, Inc., as he examines the historic medical utilization and underlying neurobiological mechanisms of opioids. Explore… Read More

Gender Differences In Depression

The prevalence of depressive disorders is higher in women than men. Why? Many factors are thought to contribute to the divergence, including biological and clinical presentations. Understanding these variances may… Read More

Webinar Summary – Gender Differences In Depression

This summary was developed utilizing the full recorded presentation of this webinar. You can access the full sourcing, polling results, recording, or presentation slides here: https://psychu.org/gender-differences-in-depression/. On March 7, 2019,… Read More

Depression: From Molecule To Man

Dr. Mark M. Rasenick examines the impact of depression in molecules, rodents, primates, and humans from a biological, genetic, and epigenetics perspective. Dr. Rasenick identifies the importance of research derived… Read More

Neuromodulation Techniques: State Of The Science

Clinicians managing patients with behavioral health issues are presented with various diagnostic and treatment challenges, spanning the areas of neurobiology, adherence, safety, and medication tolerability. Currently available pharmacotherapeutic, psychotherapeutic, and… Read More

Neurobiology Of Risk For Bipolar Disorder

Key Messages Tools that would facilitate early diagnosis, intervention, and prevention of new bipolar episodes may be of benefit to patients with bipolar disorder or who may develop bipolar disorder… Read More

Neuroinflammation & Psychiatric Illness

Key Messages Multiple lines of evidence support the role of neuroinflammatory processes in the pathogenesis of psychiatric illnesses. Neuropsychiatric disorders are frequently found among patients with autoimmune conditions; in addition,… Read More

Theories Of Bipolar Disorder Pathophysiology

This video is part 2 of a series on Bipolar Disorder, from the Psychopharmacology Collection. This video briefly reviews some of the potential molecular (eg, genetics), cellular (eg, ion dysregulation,… Read More

Inflammation In Neurological & Psychiatric Diseases

Key Messages This review article examined findings on the relationship of inflammation with neurological and psychiatric disorders. Several lines of evidence supported the role of inflammation in the pathophysiology of… Read More

Depression, Serotonin & Tryptophan

Key Messages Research into the pathophysiology of depression has moved beyond the serotonergic system to examine the interplay of wider body systems and processes. This article reviewed recent literature pertaining… Read More

Depression: From Psychopathology To Pathophysiology

Key Messages This review aimed to provide a coherent view of the underlying psychopathology and pathophysiology of depression by integrating findings from cognitive psychology and neurobiology. Cognitive psychology has developed… Read More

The Importance Of Norepinephrine In Depression

Key Messages The hypothesis that impaired serotonin (5-HT) and/or norepinephrine (NE) neurotransmission underlies depressive disorders continues to be central to treatment approaches. Several lines of evidence support a role for… Read More

The Neurobiology Of Relapse In Schizophrenia

Key Messages Relapse rates among patients with first-episode schizophrenia have been reported to exceed 80% within 5 years. This review of the neurophysiology of schizophrenia relapse suggests that dopamine may… Read More